ArticleCancers2021

Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma).

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.